Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Chrys Pulle

Dr Chrys Pulle

Practical Strategies for Behaviour Management in Dementia

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

The New Pneumococcal Vaccination for Older Adults – What You Need to Know

Prof Rodney Baber AM

Prof Rodney Baber AM

Adolescent Contraception – Common Myths

Dr Jo-Ann See

Dr Jo-Ann See

Acne Practical Cases – Trunk, Skin of Colour

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024